St. Jude Medical Inc. received European CE Mark approval and FDA clearance for the Epicor LP Cardiac Ablation System, a second generation technology that uses HIFU (high intensity focused ultrasound) to surgically ablate cardiac tissue to disrupt abnormal electrical impulses in the heart.

August 18, 2008 - ProSolv CardioVascular, a FUJIFILM company, today released ProSolv CardioVascular 4.0, a new software release featuring a Web-based application for full viewing and reporting capabilities using Web communication protocols, secured via SSL, in addition to a Web URL single-click application download and installation for easier deployment.

August 18, 2008 – Maximus, a business unit of infusion therapy firm Medegen Inc., today announced as a result of a co-marketing agreement between C.R. Bard and Medegen, the MaxPlus ClearT needleless access connector will now be included in peripherally inserted central catheter (PICC) kits sold by Bard Access Systems.

August 18, 2008 - GE Healthcare along with Olympic medical leaders today announced at the Beijing 2008 Olympic Games, initial findings that recognize risks for sudden cardiac death and musculoskeletal injuries before they happen.

The findings come from two Olympic athlete research studies conducted since the Torino 2006 Olympic Winter Games aimed at demonstrating that health monitoring and early intervention may lead to injury prevention and enhanced health.

August 15, 2008 - The American Society of Nuclear Cardiology will hold its Annual Meeting from Sept. 10-14 in Boston, MA.

Nearly 50 vendors showcase the latest in nuclear cardiology technology. A wide range of abstracts and posters will also be presented, including topics on perfusion methods, image acquisition and congestive heart failure.

For more information: www.asnc.org

August 15, 2008 - Abbott and AstraZeneca said this week they entered into an agreement for Abbott to promote AstraZeneca’s CRESTOR (rosuvastatin calcium), a medication used along with diet to reduce high cholesterol.

Under the terms of the agreement, Abbott will obtain the non-exclusive right to promote CRESTOR alongside AstraZeneca in the U.S., excluding Puerto Rico. Specific financial terms were not disclosed.

August 15, 2008 - Research indicates the feasibility of uninterrupted chest compressions during biphasic external defibrillation shock delivery using modern defibrillation equipment, which may enhance the efficacy of defibrillation and cardiocerebral resuscitation.

August 14, 2008 - Boston Scientific and FDA today informed healthcare professionals and patients of the Class I Recall of NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System, distributed from June 19, 2007 through May 5, 2008.

August 14, 2008 - TeraMedica Healthcare Technology’s Evercore Enterprise Suite has been fully tested and certified for use with IBM’s Grid Medical Archive Solution (GMAS) storage management system, TeraMedica announced yesterday.

August 14, 2008 - A new study published in the July/August 2008 issue of Journal of Women’s Health highlights the importance of women knowing their own risk factors for cardiovascular disease, and cautions that a frequently used risk assessment tool could lead to false reassurance that a woman is at low risk for heart problems.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now